Showing results (201-210 of 928) with videos related to
Sort By:
Pageof 93
Addictive Behaviors|October 10, 2020
Online recovery support meetings can help mitigate the public health consequences of COVID-19 for individuals with substance use disorderBrandon G Bergman, John F Kelly, Maurizio Fava, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 30, 2017
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive DisorderSanjay J Mathew, Ralitza Gueorguieva, Cynthia Brandt, et al.International Journal of Geriatric Psychiatry|September 7, 2006
Recognizing and engaging depressed Chinese Americans in treatment in a primary care settingAlbert Yeung, Shu-Ching Yu, Freddy Fung, et al.Journal of Psychiatric Research|June 28, 2005
Adjunctive atomoxetine for residual fatigue in major depressive disorderGeorge I Papakostas, Timothy J Petersen, Alana M Burns, et al.BMC Psychiatry|September 28, 2011
A study of the effectiveness of telepsychiatry-based culturally sensitive collaborative treatment of depressed Chinese AmericansAlbert Yeung, Kate Hails, Trina Chang, et al.Depression and Anxiety|February 24, 2004
A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatmentDavid Mischoulon, Gudrun Opitz, Karen Kelly, et al.Psychiatry Research|November 4, 2008
Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depressionPaola Pedrelli, Greg C Feldman, Sienna Vorono, et al.International Journal of Culture and Mental Health|August 1, 2014
The Engagement Interview Protocol (EIP): improving the acceptance of mental health treatment among Chinese immigrantsAlbert Yeung, Nhi-Ha T Trinh, Trina E Chang, et al.Neuropsychobiology|February 9, 2008
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetineGeorge I Papakostas, Christine M Crawford, Margaret J Scalia, et al.Journal of Affective Disorders|May 27, 2014
S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of responseJerome Sarris, George I Papakostas, Ottavio Vitolo, et al.Pageof 93